Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.720
-0.089 (-1.85%)
At close: Jul 30, 2025, 4:00 PM
4.506
-0.134 (-2.88%)
Pre-market: Jul 31, 2025, 8:55 AM EDT
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $35.11 million as of July 31, 2025. Its market cap has increased by 37.12% in one year.
Market Cap
35.11M
Enterprise Value
10.82M
1-Year Change
37.12%
Ranking
Category
Stock Price
$4.72
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $35.11M, a decrease of -51.81%. That is a compound annual growth rate of -18.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2025 | 33.58M | 3.07% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
| Nov 25, 2021 | 72.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.58B |
| Johnson & Johnson | 405.11B |
| AbbVie | 336.23B |
| UnitedHealth Group | 238.22B |
| AstraZeneca | 230.79B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 224.09B |
| Novo Nordisk | 221.96B |